206 related articles for article (PubMed ID: 29517899)
41. Identification of multiple structurally distinct, nonpeptidic small molecule inhibitors of protein arginine deiminase 3 using a substrate-based fragment method.
Jamali H; Khan HA; Stringer JR; Chowdhury S; Ellman JA
J Am Chem Soc; 2015 Mar; 137(10):3616-21. PubMed ID: 25742366
[TBL] [Abstract][Full Text] [Related]
42. Inducement of ER Stress by PAD Inhibitor BB-Cl-Amidine to Effectively Kill AML Cells.
Sun YN; Ma YN; Jia XQ; Yao Q; Chen JP; Li H
Curr Med Sci; 2022 Oct; 42(5):958-965. PubMed ID: 36245030
[TBL] [Abstract][Full Text] [Related]
43. Discovery of a novel photoswitchable PI3K inhibitor toward optically-controlled anticancer activity.
Zhang Y; Peng S; Lin S; Ji M; Du T; Chen X; Xu H
Bioorg Med Chem; 2022 Oct; 72():116975. PubMed ID: 36049360
[TBL] [Abstract][Full Text] [Related]
44. Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase.
Damgaard D; Bjørn ME; Jensen PØ; Nielsen CH
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1203-1208. PubMed ID: 28933232
[TBL] [Abstract][Full Text] [Related]
45. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
[TBL] [Abstract][Full Text] [Related]
46. Activation of Peptidylarginine Deiminase in the Salivary Glands of
Rodríguez-Rodríguez M; Herrera-Esparza R; Bollain Y Goytia JJ; Pérez-Pérez ME; Pacheco-Tovar D; Murillo-Vázquez J; Pacheco-Tovar G; Avalos-Díaz E
J Immunol Res; 2017; 2017():8959687. PubMed ID: 29318161
[TBL] [Abstract][Full Text] [Related]
47. D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.
Bicker KL; Anguish L; Chumanevich AA; Cameron MD; Cui X; Witalison E; Subramanian V; Zhang X; Chumanevich AP; Hofseth LJ; Coonrod SA; Thompson PR
ACS Med Chem Lett; 2012 Oct; 3(12):1081-1085. PubMed ID: 23420624
[TBL] [Abstract][Full Text] [Related]
48. Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism.
Dreyton CJ; Knuckley B; Jones JE; Lewallen DM; Thompson PR
Biochemistry; 2014 Jul; 53(27):4426-33. PubMed ID: 24989433
[TBL] [Abstract][Full Text] [Related]
49. The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line.
Öğüten PN; Engür Öztürk S; Dikmen M
Medicine (Baltimore); 2024 Feb; 103(8):e37015. PubMed ID: 38394536
[TBL] [Abstract][Full Text] [Related]
50. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.
Knight JS; Zhao W; Luo W; Subramanian V; O'Dell AA; Yalavarthi S; Hodgin JB; Eitzman DT; Thompson PR; Kaplan MJ
J Clin Invest; 2013 Jul; 123(7):2981-93. PubMed ID: 23722903
[TBL] [Abstract][Full Text] [Related]
51. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
Damgaard D; Senolt L; Nielsen CH
Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
[TBL] [Abstract][Full Text] [Related]
52. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.
Jones JE; Causey CP; Knuckley B; Slack-Noyes JL; Thompson PR
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):616-27. PubMed ID: 19736621
[TBL] [Abstract][Full Text] [Related]
53. Azobenzene-containing photoswitchable proteasome inhibitors with selective activity and cellular toxicity.
Blanco B; Palasis KA; Adwal A; Callen DF; Abell AD
Bioorg Med Chem; 2017 Oct; 25(19):5050-5054. PubMed ID: 28642029
[TBL] [Abstract][Full Text] [Related]
54. The Peptidylarginine Deiminase Inhibitor Cl-Amidine Suppresses Inducible Nitric Oxide Synthase Expression in Dendritic Cells.
Jang B; Ishigami A; Kim YS; Choi EK
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077055
[TBL] [Abstract][Full Text] [Related]
55. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
Slack JL; Causey CP; Luo Y; Thompson PR
ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
[TBL] [Abstract][Full Text] [Related]
56. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
[TBL] [Abstract][Full Text] [Related]
57. Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design.
Slade DJ; Fang P; Dreyton CJ; Zhang Y; Fuhrmann J; Rempel D; Bax BD; Coonrod SA; Lewis HD; Guo M; Gross ML; Thompson PR
ACS Chem Biol; 2015 Apr; 10(4):1043-53. PubMed ID: 25621824
[TBL] [Abstract][Full Text] [Related]
58. Highly Efficient Cell-Penetrating Probes of Protein Arginine Deiminases for Functional Proteomics.
Kumar S
Chembiochem; 2018 Sep; 19(17):1806-1809. PubMed ID: 29949677
[TBL] [Abstract][Full Text] [Related]
59. Induction of peptidylarginine deiminase 2 and 3 by dibutyryl cAMP via cAMP-PKA signaling in human astrocytoma U-251MG cells.
Masutomi H; Kawashima S; Kondo Y; Uchida Y; Jang B; Choi EK; Kim YS; Shimokado K; Ishigami A
J Neurosci Res; 2017 Jul; 95(7):1503-1512. PubMed ID: 27704563
[TBL] [Abstract][Full Text] [Related]
60. Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis.
Sarswat A; Wasilewski E; Chakka SK; Bello AM; Caprariello AV; Muthuramu CM; Stys PK; Dunn SE; Kotra LP
Bioorg Med Chem; 2017 May; 25(9):2643-2656. PubMed ID: 28341402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
